Controlling tumor angiogenesis and metastasis of C26 murine colon adenocarcinoma by a new matrix metalloproteinase inhibitor, KB-R7785, in two tumor models

Cancer Research

Volumn 59, Issue 6, 1999, Pages 1252-1258

  Lozonschi, Lucian ^a   Sunamura, Makoto ^a   Kobari, Masao ^a   Egawa, Shinichi ^a   Ding, Lianghao ^a   Matsuno, Seiki ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

[4 (N HYDROXYAMINO) 2 ISOBUTYL 3 METHYLSUCCINYL]PHENYLGLYCINE N METHYLAMIDE; MATRIX METALLOPROTEINASE INHIBITOR; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL CELL; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; COLON CARCINOMA; MALE; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR BLOOD FLOW;

ADENOCARCINOMA; ANIMALS; COLONIC NEOPLASMS; GLYCINE; HYDROXAMIC ACIDS; LUNG NEOPLASMS; MALE; METALLOENDOPEPTIDASES; MICE; MICE, INBRED BALB C; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; PROTEASE INHIBITORS;

EID: 0033559212     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Folkman, J. Tumor angiogenesis: therapeutic implications. N. Engl J. Med., 285: 1182-1186, 1971.
2. Folkman, J. Fighting cancer by attacking its blood supply. Sci. Am., 275: 116-119,1996.
3. Zetter, B. R. Angiogenesis and tumor metastasis. Annu. Rev. Med., 49: 407-424, 1998.
4. Liotta, L. A., Thorgeirsson, U. P., and Garbisa, S. Role of collagenases in tumor cell invasion. Cancer Metastasis Rev., 1: 277-288, 1982.
5. Mignatti, P., and Robbins, E. R. D. B. Tumor invasion through the human amnion membrane: requirement for a proteinase cascade. Cell. 47: 487-498, 1986.
6. Liotta, L. A., Wewer, U., Rao, N., Schiffmann, E., Stracke, M., Guirguis, R., Thorgeirsson, U., Muschel, R., and Sobel, M. Biochemical mechanisms of tumor invasion and metastases. Prog. Clin. Biol. Res., 256: 3-16, 1988.
7. Folkman, J. Tumor angiogenesis and tissue factor. Nat. Med., 2: 167-168, 1996.
8. Hirayama, R., Yamamoto, M., Tsukida, T., Matsuno, K., Obata, Y., Sakamoto, F., and Ikeda, S. Synthesis and biological evaluation of orally active matrix metalloproteinase inhibitors. Bioorg. Med. Chem., 5: 765-778, 1997.
9. 2+-independent adhesion pathway in lymphocyte-endothelial cell interaction. Eur. J. Immunol., 23: 439-446, 1993.
10. Algire, G. H. An adaptation of the transparent-chamber technique to the mouse. J. Natl. Cancer Inst., 4: 1-11, 1943.
11. Lehr, H. A., Leunig, M., Menger, M. D., Nolte, D., and Messmer, K. Dorsal skinfold chamber technique for intravital microscopy in nude mice. Am. J. Pathol., 143: 1055-1062, 1993.
12. Leunig, M., Yuan, F., Menger, M., Boucher, Y., Goetz A. E., Messmer, K., and Jain, R. K. Angiogenesis, microvascular architecture, microhemodynamics, and interstitial fluid pressure during early tumor growth of human adenocarcinoma LS174T in SCID mice. Cancer Res., 52: 6553-6560, 1992.
13. Endrich, B., Asaishi, K., Goetz, A., and Messmer, K. Technical report - A new chamber technique for microvascular studies in unanesthetized hamsters. Res. Exp. Med., 177: 125-134, 1980.
14. Borgstrom, P., Hillan, K. J., Sriramarao, P., and Ferrara, N. Complete inhibition of angiogenesis and growth of microtumors by anti-vascular endothelial growth factor neutralizing antibody: novel concepts of angiostatic therapy from intravital videomicroscopy. Cancer Res., 56: 4032-4039, 1996.
15. Tada, H., Shiho, O., Kuroshima, K., Koyama, M., and Tsukamoto, K. An improved colorimetric assay for interleukin 2. J. Immunol. Methods, 93: 157-165, 1986.
16. Watson, S. A., Morris, T. M., Robinson, G., Crimmin, M. J., Brown, P. D., and Hardcastle, J. D. Inhibition of organ invasion by the matrix metalloproteinase inhibitor batimastat (BB-94) in two human colon carcinoma metastasis models. Cancer Res., 55: 3629-3633, 1995.
17. Koop, S., Khokha, R., Schmidt, E. E., MacDonald, I. C., Morris, V. L., Chambers, A. F., and Groom, A. C. Overexpression of metalloproteinase inhibitor in B16F10 cells does not affect extravasation but reduces tumor growth. Cancer Res., 54: 4791-4797, 1994.
18. Chambers, A. F., and Matrisian, L. M. Changing views of the role of matrix metalloproteinases in metastasis. J. Natl. Cancer Inst., 89: 1260-1270, 1997.
19. Holmgren, L., O'Reilly, M. S., and Folkman, J. Dormancy of micrometastasis: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nat. Med., 1: 149-153, 1995.
20. Parangi, S., O'Reilly, M., Christofori, G., Holmgren, L., Grosfeld, J., Folkman, J., and Hanahan, D. Antiangiogenic therapy of transgenic mice impairs de novo tumor growth. Proc. Natl. Acad. Sci. USA, 93: 2002-2007, 1996.
21. O'Reilly, M. S., Boehm, T., Shing, Y., Fukai, N., Vasios, G., Lane, W. S., Flynn, E., Birkhead, J. R., Olsen, B. R., and Folkman, J. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell, 88: 277-285, 1997.
22. Seed, M. P., Brown, J. R., Freemantle, C. N., Papworth, J. L., Colville-Nash, P. R., Willis, D., Somerville, K. W., Asculai, S., and Willoughby, D. A. The inhibition of colon-26 adenocarcinoma development and angiogenesis by topical diclofenac in 2.5% hyaluronan. Cancer Res., 57: 1625-1629, 1997.
23. Brooks, P. C., Montgomery, A. M. P., Rosenfeld, M., Reisfeld, R. A., Hu, T., Klier, G., and Cheresh, D. A. Inlegrin αVβ3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell, 79: 1157-1164, 1994.
24. Ruegg, C., Yilmaz, A., Bieler, G., Bamat, J., Chaubert, P., and Lejeune F. J. Evidence for the involvement of endothelial cell integrin αVβ3 in the disruption of the tumor vasculature induced by TNF and IFN-γ. Nat. Med., 4: 408-414, 1998.
25. Guo, N., Krutzsch, H. C., Inman, J. K., and Roberts, D. D. Thrombospondin I and type I repeat peptides of thrombospondin I specifically induce apoptosis of endothelial cells. Cancer Res., 57, 1735-1742, 1997.